U.S. Sunscreens Aren’t Great. The FDA Could Soon Change That

The U.S. Food and Drug Administration (FDA) has approved a groundbreaking device designed to treat depression through brain stimulation at home, targeting a specific brain region known for regulating mood. This marks a significant advancement in mental health treatment options, potentially allowing patients to manage their symptoms more effectively in a familiar environment.

American officials, alongside representatives from Russia, Saudi Arabia, and Iran, expressed objections to key language regarding fossil fuels, biodiversity, and plastics in a report presented at the 7th United Nations Environment Assembly in Nairobi, Kenya. This report was the result of three years of collaborative efforts.

In 2025, the U.S. has reported over 1,900 measles cases, primarily affecting children, signaling a troubling trend towards losing its measles-free status by early next year. This resurgence raises alarms about public health and vaccination rates across the nation.

The FDA has expanded its inquiry into the Covid vaccine to include adult deaths, claiming a link to 10 children's deaths associated with the vaccine, although it has not provided evidence to substantiate these claims. This development raises significant concerns regarding vaccine safety and public trust in health authorities.

FDA officials are currently reassessing several approved therapies for treating RSV in infants, despite previous clinical trials indicating these shots were safe. This scrutiny arises amid ongoing public discussions about vaccine safety and efficacy, particularly concerning childhood vaccinations.